Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Ronald S. Duman, George K. Aghajanian
Science (2012) Vol. 338, Iss. 6103, pp. 68-72
Open Access | Times Cited: 1321

Showing 26-50 of 1321 citing articles:

BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack, Manabu Fuchikami, J. M. Dwyer, et al.
The International Journal of Neuropsychopharmacology (2014) Vol. 18, Iss. 1, pp. pyu033-pyu033
Open Access | Times Cited: 343
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F. Ionescu, Dong‐Jing Fu, Xin Qiu, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 1, pp. 22-31
Open Access | Times Cited: 337
EFFECTS OF KETAMINE ON EXPLICIT AND IMPLICIT SUICIDAL COGNITION: A RANDOMIZED CONTROLLED TRIAL IN TREATMENT-RESISTANT DEPRESSION
Rebecca B. Price, Dan V. Iosifescu, James W. Murrough, et al.
Depression and Anxiety (2014) Vol. 31, Iss. 4, pp. 335-343
Open Access | Times Cited: 317
Connecting inflammation with glutamate agonism in suicidality
Sophie Erhardt, Chai K. Lim, Klas R. Linderholm, et al.
Neuropsychopharmacology (2012) Vol. 38, Iss. 5, pp. 743-752
Open Access | Times Cited: 317
Identification of a prefrontal cortex-to-amygdala pathway for chronic stress-induced anxiety
Wei-Zhu Liu, Wen-Hua Zhang, Zhi-Heng Zheng, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 314
The Role of BDNF on Neural Plasticity in Depression
Tao Yang, Zheng Nie, Haifeng Shu, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 305
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 952-964
Open Access | Times Cited: 288
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
Kenji Hashimoto
Psychiatry and Clinical Neurosciences (2019) Vol. 73, Iss. 10, pp. 613-627
Open Access | Times Cited: 286
Qualitative Research Methods
Alan E. Kazdin
Cambridge University Press eBooks (2021), pp. 224-245
Closed Access | Times Cited: 284
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
James W. Murrough, Laili Soleimani, Kaitlin E. DeWilde, et al.
Psychological Medicine (2015) Vol. 45, Iss. 16, pp. 3571-3580
Closed Access | Times Cited: 276
Microglial Dysregulation in Psychiatric Disease
Luciana Romina Frick, Kyle A. Williams, Christopher Pittenger
Clinical and Developmental Immunology (2013) Vol. 2013, pp. 1-10
Open Access | Times Cited: 272
Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After Inflammation
Ji‐chun Zhang, Jin Wu, Yūkō Fujita, et al.
The International Journal of Neuropsychopharmacology (2015) Vol. 18, Iss. 4
Open Access | Times Cited: 271
Ketamine Treatment and Global Brain Connectivity in Major Depression
Chadi G. Abdallah, Lynnette A. Averill, Katherine A. Collins, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 6, pp. 1210-1219
Open Access | Times Cited: 271
Caffeine acts through neuronal adenosine A 2A receptors to prevent mood and memory dysfunction triggered by chronic stress
Manuella P. Kaster, Nuno J. Machado, Henrique B. Silva, et al.
Proceedings of the National Academy of Sciences (2015) Vol. 112, Iss. 25, pp. 7833-7838
Open Access | Times Cited: 269
Suicide risk assessment and intervention in people with mental illness
Shay‐Lee Bolton, David Gunnell, Gustavo Turecki
BMJ (2015) Vol. 351, Iss. nov09 1, pp. h4978-h4978
Open Access | Times Cited: 269
Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity
Danielle M. Gerhard, Eric S. Wohleb, Ronald S. Duman
Drug Discovery Today (2016) Vol. 21, Iss. 3, pp. 454-464
Open Access | Times Cited: 266
Acute Suppression of Spontaneous Neurotransmission Drives Synaptic Potentiation
E. D. Nosyreva, Kristen L. Szabla, Anita E. Autry, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 16, pp. 6990-7002
Open Access | Times Cited: 259
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
M. Lévy, Fabien Boulle, Harry W.M. Steinbusch, et al.
Psychopharmacology (2018) Vol. 235, Iss. 8, pp. 2195-2220
Open Access | Times Cited: 259
The Innate Immune Receptors TLR2/4 Mediate Repeated Social Defeat Stress-Induced Social Avoidance through Prefrontal Microglial Activation
Xiang Nie, Shiho Kitaoka, Kohei Tanaka, et al.
Neuron (2018) Vol. 99, Iss. 3, pp. 464-479.e7
Open Access | Times Cited: 258
Improvement in suicidal ideation after ketamine infusion: Relationship to reductions in depression and anxiety
Elizabeth D. Ballard, Dawn F. Ionescu, Jennifer L. Vande Voort, et al.
Journal of Psychiatric Research (2014) Vol. 58, pp. 161-166
Open Access | Times Cited: 256
An excitatory synapse hypothesis of depression
Scott M. Thompson, Angy J. Kallarackal, Mark D. Kvarta, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 5, pp. 279-294
Open Access | Times Cited: 250
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman, Ronald S. Duman
Neuroscience Letters (2015) Vol. 601, pp. 20-29
Open Access | Times Cited: 241
GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine
Rong-Jian Liu, Manabu Fuchikami, Jason M. Dwyer, et al.
Neuropsychopharmacology (2013) Vol. 38, Iss. 11, pp. 2268-2277
Open Access | Times Cited: 238
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications
Alexandria Tartt, Madeline Mariani, René Hen, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 6, pp. 2689-2699
Open Access | Times Cited: 229
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
Gerard Sanacora, Mark A. Smith, Sanjeev Pathak, et al.
Molecular Psychiatry (2013) Vol. 19, Iss. 9, pp. 978-985
Open Access | Times Cited: 223

Scroll to top